NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
SYRS Syros Pharmaceuticals
- 0.2000
- -0.0018-0.89%
Close Dec 20 16:00 ET
- 0.2069
- +0.0069+3.45%
Post 20:01 ET
5.37MMarket Cap-0.07P/E (TTM)
0.2200High0.2000Low2.84MVolume0.2100Open0.2018Pre Close603.61KTurnover21.62%Turnover RatioLossP/E (Static)26.83MShares8.170052wk High-0.48P/B2.63MFloat Cap0.183052wk Low--Dividend TTM13.14MShs Float243.7500Historical High--Div YieldTTM9.91%Amplitude0.1830Historical Low0.2120Avg Price1Lot Size
Syros Pharmaceuticals News
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 8-K: Current report
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Simonian Nancy A
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Simonian Nancy A
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Haas Jason
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chee Conley
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Quirk Gerald E
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Roth David
Syros Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Stephens Kristin
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Syros Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.